Executive Steering Group

Currently an Honorary Professor of Innovation and AI in the School of Medicine at the University of Surrey, Hatim sits on the National Institute for Health and Care Excellence Technology Appraisals Committee, the Responsible AI UK Health and Care Group and the Responsible AI Institute Sustainable AI Consortium. Hatim holds Membership of the Royal College of General Practitioners, and Fellowship of Advance Higher Education and the British Computer Society.
 
As an international speaker, he has contributed to the publication of academic papers and white papers spanning workforce, education reform, innovation, primary care, digital health, and AI. Hatim is an advocate for safe, ethical, and responsible digital and AI transformation and ensuring workforce preparedness for new innovations and technologies in health and care.

Junaid Bajwa, Senior Partner, Flagship Pioneering
Junaid is a Senior Partner at Flagship Pioneering, leading the UK division and serving as a Science Partner for Pioneering Intelligence globally. He is also a practicing physician in the NHS. Previously, as Chief Medical Scientist at Microsoft Research, Junaid focused on integrating trusted, reliable, and human-centered AI into medicine, leading strategic partnerships and spearheading Responsible AI initiatives. With extensive experience in primary and secondary care, public health, and roles as a payer and policy maker, Junaid’s work spans healthcare systems across the US, Europe, Australia, the Middle East, and Singapore. Academically, he holds positions as a Clinical Associate Professor at University College London (UCL) and as a Visiting Scientist at both the Harvard School of Public Health and NTU in Singapore.

He is a mentor at EIT Health, a non-executive director at Herts Urgent Care, and a board advisor to several companies including Tickets for Good. He is passionate about improving health outcomes, delivering social impact, and enabling innovation and collaboration across the sector. He has a proven track record of leading change, turnaround, and transformation initiatives in complex and challenging environments, both as an NHS CEO and a consultant.

Her senior management experience in NHS England brings effective and trusted relationships with senior NHS stakeholders. Successfully transcending silos to deliver mutually beneficial impact to optimise business/healthcare development and patient outcomes.

She is highly connected with the external environment, demonstrably shaping and partnering with senior key healthcare system payors and providers, ensuring that CHASE is at the front of the change curve. Leading to the successful implementation of countrywide NHS/industry partnership working programs. She has experience of transforming organisations by long and short-term value creation and capability building.

Her leadership experience working in the private and public healthcare sector allows for her to intrinsically interpret changes in healthcare, which allows for organisations to be forward thinking.

Kristian Howells, Group Commercial Director, Medtronic Limited
With a career spanning over 27 years, initially in Covidien and subsequently with Medtronic, Kristian is an experienced leader in MedTech. His experience covers multiple specialities including data analytics, contracting, procurement, supply chain, sales, and sales leadership. He has held various senior positions including leading Medtronic’s respiratory business, indirect sales channels and contracts and pricing function.

In his current role, Kristian is responsible for commercial policy alignment and external affairs for Medtronic UK & Ireland. Additionally, he leads on programmes for Sustainability, Commercial Model development, and Market Access, and sponsors the Medtronic Young Professionals Network.

He is driven by a passion to solve complex healthcare challenges, leading several key projects for Medtronic which have delivered on this. Notably MedPoints, a $1bn commercial program targeting investment in frontline services, and a blueprint for a drone-based logistic model for MedTech, both derived from his intrinsic knowledge of the NHS and government strategic drivers.

Kristian has been a passionate and active member of the Association of British HealthTech Industries (ABHI) for many years, supporting various member forums including Sustainability, Commercial, Value and Access, and eProcurement. Kristian joined the ABHI Board of Directors in 2024.

Jill Loader, Director, Dr J Loader Ltd
Pharmacy Contract Advisor to National Pharmacy Association
Associate Primary Care Commissioning
Formerly Deputy Director responsible for Community Pharmacy Policy and Strategy and Deputy Director responsible for Community Pharmacy Commissioning at NHS England (central team)

Jill Loader is a pharmacist with 35 years’ experience in a wide variety of NHS roles and is a national expert in community pharmacy commissioning. She has worked in front-line hospital, community services and community pharmacy roles as well as in research and academia. She has provided internal consultancy to the NHS through internal management and support secondments and has held both local and national policy, strategy and commissioning roles in medicines optimisation and community pharmacy. Until recently Jill was responsible for commissioning £3 billion of pharmaceutical services for the NHS in England and was a member of the negotiating team for the Community Pharmacy Contractual Framework.
Jill has held the most senior pharmacy roles for England in Community Pharmacy Commissioning and Community Pharmacy Policy and Strategy. Jill has significant expertise in NHS medicines and pharmacy policy and commissioning having worked for the NHS Executive, Health Authorities, Strategic Health Authorities and NHS Regions in the field of medicines optimisation and medicines safety and on large scale commercial contracts and Pharmaceutical Industry joint working projects.
Jill is passionate about the clinical role and expertise of community pharmacy teams in the heart of their local communities, she has championed community pharmacy commissioning of clinical services at national and local level from flu and Covid-19 vaccination to Pharmacy First and the pathfinders for independent prescribing in community pharmacy.
Jill is currently working with the National Pharmacy Association advising on contractual matters and with others on developing thinking on community pharmacy policy and strategy.

As a Primary Care Network Clinical Director, Dr Mahmoodi has a proven track record in forging strategic partnerships across sectors to deliver value-based care. His ability to unite stakeholders—whether in research, digital health, or system redesign—has led to scalable models of care that benefit patients, staff, and the wider NHS. He is particularly known for cultivating collaborations that deliver mutual gain, long-term sustainability, and measurable impact.

Dr Mahmoodi has championed the integration of AI tools, automated triage, and seamless registration pathways to streamline access without compromising on clinical safety or personalisation. His work bridges operational leadership with wider system thinking, enabling innovation at both the practice and regional level.

A passionate advocate for reducing health inequalities through partnership and purposeful design, Dr Mahmoodi brings grounded clinical experience together with entrepreneurial drive to reshape what is possible in modern primary care.

Andy Poll, Senior Director, UK&I Head of Value, Access and Pipeline Strategy, Incyte
With over 20 years of experience in the pharmaceutical and biotech industry, Andy is a seasoned market access and Health Technology Assessment (HTA) leader with a strong background in health economics. Andy’s career has spanned several leading global pharmaceutical companies, including GSK, ViiV Healthcare, Gilead Sciences, Amgen, Pierre Fabre, and Incyte, where he has held senior leadership roles driving strategic insights and value-driven solutions to support market access and reimbursement.

A key aspect of Andy’s role has been building and nurturing effective partnerships with the NHS and other healthcare systems, having led cross-functional teams and collaborative projects focused on demonstrating the value of innovative therapies, supporting HTA submissions, and developing health economic models tailored to NHS priorities and patient needs. This experience includes working closely with NHS stakeholders to co-create solutions that improve patient access and outcomes, while aligning with system sustainability goals.

Andy is passionate about leveraging health economic analyses more effectively, the patient perspective, and developing partnership working opportunities that ultimately better inform decision-making with regard to medicines access and improved patient care.

Nabil Rastani, Strategic Partnership Policy Manager, ABPI
Nabil is a Strategic Partnership Policy Manager at the ABPI, having been appointed to the role in October 2022. Prior to this he worked at Lexington Communications as a Consultant, as well as Dods Parliamentary Communications as a Senior Political Consultant and Lilly UK as a Public Affairs Associate.

Luella Trickett, Executive Director, Devices, Value & Access, ABHI
Luella joined ABHI in 2019, with over 25 years’ experience in the pharmaceutical and HealthTech industries. Her career has seen her hold numerous specialist manufacturing and commercial roles at Baxter Healthcare, with responsibility for a range of product portfolios across the HealthTech spectrum within the UK, Europe, Middle East and Africa.
In 2012, Luella was seconded to the Department of Health for nine months as the Industry Liaison for the NHS Procurement Review, a role which saw her engage with government and the wider life sciences sector to facilitate the sharing of ideas and best practice.

From 2015, Luella led Baxter Healthcare’s Government Affairs and Public Policy agenda, where she was tasked with managing key policies impacting the HealthTech sector and the NHS – supporting change that enabled the adoption and spread of innovations that deliver whole-system value across healthcare settings.

Before joining ABHI, Luella Chaired the Association’s Public Affairs Policy Group, and has been a Director of the Board at the British Specialist Nutrition Association.

Deborah Flanagan, Director, Gilead